Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS
10:16am, Tuesday, 28'th Oct 2025
Evaluate the expected performance of Alnylam (ALNY) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metric
Alnylam Pharmaceuticals, Inc. $ALNY Stock Position Lessened by Yousif Capital Management LLC
03:49am, Friday, 24'th Oct 2025
Yousif Capital Management LLC reduced its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 6.3% during the second quarter, according to the company in its most recent Form 13F fil
Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Thursday, 23'rd Oct 2025
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Alnylam (ALNY) Might be Well Poised for a Surge
01:21pm, Monday, 20'th Oct 2025
Alnylam Pharmaceuticals (ALNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile Market
08:00am, Saturday, 18'th Oct 2025
S&P 500 giant Walmart and a profitable biotech are actionable, leading five stocks to watch amid a tricky market environment.
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
08:00am, Thursday, 16'th Oct 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter endi
Are You Looking for a Top Momentum Pick? Why Alnylam Pharmaceuticals (ALNY) is a Great Choice
01:01pm, Wednesday, 15'th Oct 2025
Does Alnylam Pharmaceuticals (ALNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?
11:21am, Wednesday, 15'th Oct 2025
Investors need to pay close attention to ALNY stock based on the movements in the options market lately.
Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock
10:51am, Tuesday, 14'th Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
10:41am, Tuesday, 14'th Oct 2025
Here is how Alnylam Pharmaceuticals (ALNY) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.
Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?
12:05pm, Wednesday, 01'st Oct 2025
ALNY's portfolio of rare disease and cardiovascular drugs is boosting revenues and reducing reliance on Amvuttra.
Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran
07:30am, Wednesday, 01'st Oct 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN Car
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new analyses of the HELIOS-B Phase 3 study of AMVUT
Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term
10:51am, Wednesday, 24'th Sep 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY ) Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum September 23, 2025 8:00 AM EDT Company Participants Jeffrey Poulton - C
